Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konoplev

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Cancer|September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemiaFarhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
American Journal of Hematology|January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remissionNaveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
American Journal of Hematology|August 18, 2018
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survivalRita Assi, Hatice D Gur, Sanam Loghavi, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Cancer Biology & Therapy|July 13, 2012
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironmentOlga Frolova, Ismael Samudio, Juliana Maria Benito, et al.
American Journal of Hematology|January 20, 2023
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangementsMaria Siddiqui, Sergej Konoplev, Ghayas Issa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2012
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomasDavid S Hong, Razelle Kurzrock, Jeffrey G Supko, et al.
Haematologica|September 2, 2017
Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patientsNitin Jain, Xinyan Lu, Naval Daver, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2022
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromesAli Sakhdari, Caleb Class, Guillermo Montalban-Bravo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 22, 2026
Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study from the BCR::ABL1 Pathology GroupQiudan Shen, Xiaoyan Huang, Xiaoqiong Wang, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Cancer|September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemiaFarhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
American Journal of Hematology|January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remissionNaveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
American Journal of Hematology|August 18, 2018
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survivalRita Assi, Hatice D Gur, Sanam Loghavi, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Cancer Biology & Therapy|July 13, 2012
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironmentOlga Frolova, Ismael Samudio, Juliana Maria Benito, et al.
American Journal of Hematology|January 20, 2023
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangementsMaria Siddiqui, Sergej Konoplev, Ghayas Issa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2012
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomasDavid S Hong, Razelle Kurzrock, Jeffrey G Supko, et al.
Haematologica|September 2, 2017
Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patientsNitin Jain, Xinyan Lu, Naval Daver, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2022
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromesAli Sakhdari, Caleb Class, Guillermo Montalban-Bravo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 22, 2026
Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study from the BCR::ABL1 Pathology GroupQiudan Shen, Xiaoyan Huang, Xiaoqiong Wang, et al.
Pageof 26